Death, Serious Injuries Lead To Class I Recall For Boston Scientific’s Emblem Electrode
Executive Summary
The US FDA affixed its highest-risk classification to a recall of the electrode, which is part of the company’s Emblem S-ICD system.
You may also be interested in...
Déjà Vu: Boston Scientific’s Emblem Racks Up Another Class I Recall This Month
The US FDA on 19 February designated a recall of the Emblem S-ICD Subcutaneous Implantable Cardioverter Defibrillator as high-risk class I. The recall comes on the heels of a second, separate class I recall for the Emblem electrode on 2 February.
HRS 2020: Boston Scientific’s Emblem S-ICD Proves Safe And Effective In ‘Sickest Population’
Results of two studies presented at the Heart Rhythm Society Scientific Sessions support the subcutaneous implantable cardioverter defibrillator as an alternative to ICDs with transvenous leads.
FDA Adds 7 New Tools To Its Regulatory Science Toolbox
The US agency has updated its Catalog of Regulatory Science Tools.
Existing Subscriber?
Sign in to continue reading.
Need a specific report? 1000+ reports available
Buy Reports
Need a specific report? 1000+ reports available
Buy Reports
New to Medtech Insight?
Start a free trial today!
Register for our free email digests:
Register for our free email digests: